Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 05:54 PM EDT
-0.80% (1D)
| Bid | 1.22 |
| Market Cap | 14.03M |
| Revenue (ttm) | 5.7M |
| Net Income (ttm) | -12.79M |
| EPS (ttm) | -1.32 |
| PE Ratio (ttm) | -0.94 |
| Forward PE | -0.67 |
| Analyst | Strong Buy |
| Ask | 1.35 |
| Volume | 99,478 |
| Avg. Volume (20D) | 1,226,096 |
| Open | 1.32 |
| Previous Close | 1.25 |
| Day's Range | 1.24 - 1.32 |
| 52-Week Range | 0.95 - 5.95 |
| Beta | 1.45 |
About MRKR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Marker Therapeutics has released their quartely earnings
on Aug 14, 2025:
Next Earnings Release
Marker Therapeutics Inc. is scheduled to release its earnings on
Nov 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+33.33%
Marker Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
-7.44%
Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.